Inclusion in limited distribution drug network reduces time to dalfampridine access in patients with multiple sclerosis at a health-system specialty pharmacy-Reference-Cited by-同舟云学术

Inclusion in limited distribution drug network reduces time to dalfampridine access in patients with multiple sclerosis at a health-system specialty pharmacy

Published:2021-02 Issue:2 Volume:27 Page:256-262
ISSN:2376-0540
Container-title:Journal of Managed Care & Specialty Pharmacy
language:en
Short-container-title:JMCP

Author:

Peter Megan E¹,Markley Brandon¹,DeClercq Josh²,Choi Leena²,Givens Gabrielle³,Zuckerman Autumn D¹,Banks Aimee¹

Affiliation:

1. Vanderbilt Specialty Pharmacy Services, Vanderbilt University Medical Center, Nashville, TN.

2. Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN.

3. Lipscomb University College of Pharmacy, Nashville, TN.

Publisher

Academy of Managed Care Pharmacy

Subject

Health Policy,Pharmaceutical Science,Pharmacy

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insurance Approval Delay of Biologic Therapy Dose Escalation Associated with Disease Activity in Patients with Inflammatory Bowel Disease;Digestive Diseases and Sciences;2023-09-19

2. Exploring healthcare providers’ experiences with specialty medication and limited distribution networks;PLOS ONE;2022-08-15

3. Health-system specialty pharmacy role and outcomes: A review of current literature;American Journal of Health-System Pharmacy;2022-08-02

4. Implementation of an integrated pharmacist collaborative care model in specialty disease state clinics;American Journal of Health-System Pharmacy;2022-08-01

5. Implementation of a pharmacist‐managed population health monitoring tool for disease modifying therapies in treatment of patients with multiple sclerosis in a veterans affairs medical center;JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY;2021-09-29